STERIS’ (TSE:STE – Free Report) – Equities research analysts at Raymond James cut their FY2026 EPS estimates for STERIS’ in a note issued to investors on Tuesday, October 15th. Raymond James analyst M. Barth now anticipates that the company will post earnings per share of $0.67 for the year, down from their previous estimate of $0.74.
STERIS’ Price Performance
STERIS’ (TSE:STE – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The business had revenue of C$231.38 million during the quarter, compared to analyst estimates of C$226.20 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- NYSE Stocks Give Investors a Variety of Quality Options
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
